Your browser doesn't support javascript.
loading
Adjuvant rituximab, a potential treatment for the young patient with Graves' hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial.
Cole, Michael; Hynes, Ann Marie; Howel, Denise; Hall, Lesley; Abinun, Mario; Allahabadia, Amit; Barrett, Timothy; Boelaert, Kristien; Drake, Amanda J; Dimitri, Paul; Kirk, Jeremy; Zammitt, Nicola; Pearce, Simon; Cheetham, Tim.
Afiliação
  • Cole M; Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.
  • Hynes AM; Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK.
  • Howel D; Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.
  • Hall L; Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK.
  • Abinun M; Institute of Cellular Medicine, Newcastle University, Great North Children's Hospital, Newcastle upon Tyne, UK.
  • Allahabadia A; Academic Directorate of Diabetes and Endocrinology, Royal Hallamshire Hospital, Sheffield, UK.
  • Barrett T; C/O Diabetes Unit, Birmingham Children's Hospital, Birmingham, UK.
  • Boelaert K; Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, Institute of Biomedical Research, University of Birmingham, Birmingham, UK.
  • Drake AJ; Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh, UK.
  • Dimitri P; The Academic Unit of Child Health, Sheffield Children's NHS Trust Western Bank, Sheffield, UK.
  • Kirk J; Department of Endocrine, Birmingham Children's Hospital, Birmingham, UK.
  • Zammitt N; Edinburgh Centre for Endocrinology and Diabetes, Royal Infirmary of Edinburgh, Edinburgh, UK.
  • Pearce S; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Cheetham T; Department of Paediatric Endocrinology, Institute of Genetic Medicine, Newcastle University, Great North Children's Hospital, Newcastle upon Tyne, UK.
BMJ Open ; 9(1): e024705, 2019 01 21.
Article em En | MEDLINE | ID: mdl-30670519

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antitireóideos / Doença de Graves / Rituximab / Fatores Imunológicos Tipo de estudo: Guideline Aspecto: Ethics Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: BMJ Open Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antitireóideos / Doença de Graves / Rituximab / Fatores Imunológicos Tipo de estudo: Guideline Aspecto: Ethics Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: BMJ Open Ano de publicação: 2019 Tipo de documento: Article